Patents by Inventor Jan Nieuwenhuis

Jan Nieuwenhuis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020161371
    Abstract: The invention relates to a fixative device for bone tissue, which device comprises a copolymer of a polyalkylene glycol and an aromatic polyester.
    Type: Application
    Filed: February 1, 2002
    Publication date: October 31, 2002
    Applicant: Iso Tis N.V.
    Inventors: Jeroen Mattijs Bezemer, Joost Robert De Wijn, Jan Nieuwenhuis, Paul Carel Hubertus De Joode, Clements Antoni Van Blitterswijk
  • Publication number: 20020128378
    Abstract: The invention relates to a process for molding a copolymer of a polyalkylene glycol terephthalate and an aromatic ester, comprising the steps of: a) preparing a solution of the copolymer in a suitable first solvent; and b) forming a gel of the solution.
    Type: Application
    Filed: January 15, 2002
    Publication date: September 12, 2002
    Applicant: IsoTis N.V.
    Inventors: Jeroen Mattijs Bezemer, Joost Robert de Wijn, Jan Nieuwenhuis
  • Patent number: 5053485
    Abstract: A polymer lactide is prepared by the polymerization of meso-3,6-dimethyl-1,4-dioxane-2,5-dione or mesodilactide and, if desired, other monomers. The mesolactide monomer has preferably a free acid content of less than 1 meq/kg dilactide and is then polymerized in a manner known per se. The compositions containing polymesolactide obtained according to this process do not posess the typical characteristics of poly-DL-lactide, poly-D-lactide or poly-L-lactide. A shorter degradation time of a substrate based on the present polymer is unofficial for several purposes. The present polymers have a good biocompatibility and are thus suited for bone plates, clamps and sutures and controlled release of biologically active compounds. The present polylactides and/or copolymers thereof have the benefit of a good biodegradability, biocompatibility, non-toxicity and non-mutagenicity.
    Type: Grant
    Filed: June 12, 1990
    Date of Patent: October 1, 1991
    Assignee: C.C.A. Biochem B.V.
    Inventors: Jan Nieuwenhuis, Arie C. Mol